95 results found.
        
BARE BONES® - August 1, 2013
Smith & Nephew reported 2Q13 Advanced Surgical Devices revenue of US $741MM, +1% from 2Q12. (Hips -1%; Knees -1%; Sports Medicine Joint Repair +6%; Arthroscopic Enabling Tech...
BARE BONES® - May 2, 2013
Smith & Nephew reported 1Q13 Advanced Surgical Devices revenue of US $760MM, -2% from 1Q12. (Hips $167MM, -6%, Knees $219MM, -6%; Sports Medicine Joint Repair $120MM, +4%; Art...
1Q13 Revenue: Smith & Nephew
Advanced Surgical Devices $760MM, -2% (U.S. -2%, Established Markets -7%, Emerging/International Markets +16%) Hips $167MM, -6% (-3% excluding Birmingham Hip) (U.S. -8%, ex-U.S. -4%) Knees $219MM, -6% (U.S. -5%, ex-U.S. -8%) Sports Medicine Joi...
4Q12 and 2012 Revenue: Smith & Nephew
Advanced Surgical Devices $3,108MM, +2% (U.S. $1,449MM, +1%; Other Established Markets $1,298MM, +1%; Emerging and International Markets $361MM, +10%) Hips $666MM, -3% Knees $874MM, +3% Sports Medicine Joint Repair $521MM, +8% Ar...
2Q13 Revenue: Smith & Nephew
Advanced Surgical Devices $741MM, +1% (U.S. $338MM, -1%; Emerging/International $106MM, +16%; Other Established Markets $297MM, -2%) Hips $161MM, -1% (U.S. -5%, ex-U.S. +2%) Knees $214MM, -1% (U.S. -3%, ex-U.S. +1%) Sports Medicine Joint Repair...
3Q12 Earnings: Smith & Nephew
Advanced Surgical Devices (ASD) $698MM, flat (U.S. $326MM, flat; Established Markets $290MM, -1%; Emerging/International Markets $82MM, +3%; China +20%) Hips $149MM, flat excluding BHR (BHR -36%) (U.S. -5%, ex-U.S. -3%) Knees $193MM, -1% (U.S. flat, ex-U.S. -...
3Q12 Earnings: ArthroCare
$57.0MM, +5% (Americas $37.1MM, +9%; International $19.9MM, -3%) Sports Medicine $55.2MM, +8% (Americas $36.7MM, +11%; International $18.4MM, +4%) Other [includes spine] $1.8MM, -23% (Americas $322MM, -51%; International $1.5MM, -12%)   ...
BARE BONES® - November 1, 2012
Smith & Nephew reported 3Q12 Advanced Surgical Devices revenue of US $698MM, flat vs. 3Q11. (Hips $149MM, flat; Knees $193MM, -1%; Sports Medicine Joint Repair $126MM, +8%; Arthroscopic Enabli...
2Q12: A First Look at Earnings
ORTHOWORLD’s estimates place preliminary 2Q12 market growth at 5% over 2Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 2Q12, unless otherwise noted. Exhibit 1 Orthopaedic Sales Increas...
BARE BONES® - August 2, 2012
Smith & Nephew reported 2Q12 Advanced Surgical Devices revenue of US $774MM, +2% from 2Q11. (Hips $165MM, -5%; Knees $219MM, +3%; Sports Medicine Joint Repair $127MM, +10%; Arthroscopic Enabli...
First Look at Quarterly Results: 1Q12 vs. 1Q11
ORTHOWORLD’s preliminary estimates place overall 1Q12 market growth at 3% over 1Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 1Q12, unless noted otherwise. Exhibit 1 Orthopaedic Sales1 Increase...
Continuing 2011 Results, Including AAOS Conference Highlights
The orthopaedic industry appears to be tilting its focus from implant materials and toward implant alignment and personalization, per analyst review of the 2012 meeting of the American Academy of Orthopaedic Surgeons (AAOS). On the floor and in recent earnings calls, companies noted observatio...
The Next Look at 2011 Results
ORTHOWORLD’s preliminary estimates place overall 2011 market growth at 5% over 2010, as displayed in Exhibit 1. Performance highlights follow, and address both 4Q10 and 2011, as indicated.                                      ...
3Q11: A First Look at Financials: Smith & Nephew
SMITH & NEPHEW $774MM, +4%* Orthopaedics $548MM, +3% (U.S. +1%, Europe +3%, Rest of World +9%) * Hips $162MM, -2% (U.S. -6%, ex-U.S. +2%) * Knees $202MM, +6% (U.S. +5%, ex-U.S. +6%) * Trauma $113MM, +4% (U.S. flat, ex-U.S. +8%) *...
First Look at 2Q11 Results: Smith & Nephew
SMITH & NEPHEW $819MM, +4%* Orthopaedics $588MM, +4% (U.S. +4%, Europe +2%, Rest of World +6%) * Hips flat (U.S. -2%, ex-U.S. +2%) * Knees +7% (U.S. +10%, ex-U.S. +3%) * Trauma $115MM, +4% (U.S. +2%, ex-U.S. +7%) * Clinical Thera...
Next Round of 1Q11 Results: Seikagaku
SEIKAGAKU (for fiscal year ended 3/31/11) ¥27.1BB (~US $334MM), -2% f * Following the earthquake, two of three facilities resumed normal operations; one maintaining stable supply of chondroitin sulfate through sourcing of materials from other supplier...
First Look at 1Q11 Results: Smith & Nephew
SMITH & NEPHEW $823MM, +3%* Orthopaedics $590MM, +2% (U.S. +5%, Europe -2%, Rest of World +3%) * Hips $184MM, -2% (U.S. -4%, ex-U.S. -1%) * Knees $224MM, +5% (U.S. +10%, ex-U.S. flat) * Trauma $116MM, +6% (U.S. +7%, ex-U.S. +5%) ...
More 2010 Results: ArthroCare
ARTHROCARE $244.4MM, +10% * Sports Medicine $231.9MM, +11% (ex-U.S. +13%) * Other (includes Spine) $12.4MM, -5% 4Q10 revenue: $63.2MM, flat * Sports Medicine $59.8MM, +1% * Other (includes Spine) $3.4MM, -18%
Orthopaedic Sales Increases By Product Segment: 2010 vs. 2009

A First Look at 2010 Results: Smith & Nephew
SMITH & NEPHEW $3,050MM, +3% (Note: Excludes wound management) * Orthopaedics $2,195MM, +2% (U.S. +2%, Europe +1%, Rest of World +4%) * Hips flat * Knees +5% * Trauma +3% * Clinical Therapies -5% Endoscopy $855MM, +7% ...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group